Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Core Insights - Prenetics Global Limited has launched Daily Ultimate Longevity, a supplement targeting all 12 hallmarks of aging, reinforcing IM8's rapid growth in the supplement industry [1][3][4] - IM8 has achieved a compound annual growth rate of 2,457%, with monthly revenue increasing from approximately $600,000 to $6.6 million within nine months [1][4] - The global longevity market is projected to reach $314 billion by 2030, positioning IM8 at the forefront of this expanding market [7] Company Overview - Prenetics is a leading consumer health sciences company, with IM8 being one of the fastest-growing supplement brands co-founded by David Beckham [1][11] - The company maintains a strong financial foundation with over $90 million in liquid assets, including approximately $60 million in cash and 255.4 Bitcoin valued at around $31.6 million [10] Product Details - Daily Ultimate Longevity is formulated with IM8's proprietary 5-Complex System, delivering therapeutic doses of clinically-validated ingredients in a powder format [3][5][8] - The product is designed to target key aging pathways such as cellular senescence and mitochondrial dysfunction, supported by human clinical research [5][6][8] - It is priced at $149 for a one-time purchase and $119 per month for subscription, reflecting its premium positioning in the market [9] Market Positioning - The launch of Daily Ultimate Longevity is seen as a category-defining innovation in the rapidly growing longevity market [7][8] - The product's formulation includes high-dose glycine, taurine, and other key ingredients aimed at comprehensive cellular support and energy enhancement [8][12]